[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Franzoni et al., 2020 - Google Patents

Comparison of macrophage responses to African swine fever viruses reveals that the NH/P68 strain is associated with enhanced sensitivity to type I IFN and cytokine …

Franzoni et al., 2020

View HTML
Document ID
16395867234136564707
Author
Franzoni G
Razzuoli E
Dei Giudici S
Carta T
Galleri G
Zinellu S
Ledda M
Angioi P
Modesto P
Graham S
Oggiano A
Publication year
Publication venue
Pathogens

External Links

Snippet

African swine fever (ASF) poses a severe threat to the global pig industry for which currently there is no available vaccine. The aetiological ASF virus (ASFV) has a predilection for cells of the myeloid lineage, however little is known about its interaction with polarised …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Similar Documents

Publication Publication Date Title
Franzoni et al. Comparison of macrophage responses to African swine fever viruses reveals that the NH/P68 strain is associated with enhanced sensitivity to type I IFN and cytokine responses from classically activated macrophages
Wu et al. Current state of global African swine fever vaccine development under the prevalence and transmission of ASF in China
Ramirez-Medina et al. Differential effect of the deletion of African swine fever virus virulence-associated genes in the induction of attenuation of the highly virulent Georgia strain
Zhang et al. Deletion of the L7L-L11L genes attenuates ASFV and induces protection against homologous challenge
Schountz Immunology of bats and their viruses: challenges and opportunities
Razzuoli et al. Modulation of type I interferon system by African swine fever virus
Bo et al. A review of pseudorabies virus variants: genomics, vaccination, transmission, and zoonotic potential
Han et al. Infectious bronchitis virus infection induces apoptosis during replication in chicken macrophage HD11 cells
Pershin et al. A long-term study of the biological properties of ASF virus isolates originating from various regions of the Russian Federation in 2013–2018
Deutschmann et al. Taking a promising vaccine candidate further: efficacy of ASFV-G-ΔMGF after intramuscular vaccination of domestic pigs and Oral vaccination of wild boar
Shi et al. The emergence of a vv+ MDV can break through the protections provided by the current vaccines
Tang et al. Identification of the immediate-early genes of cyprinid herpesvirus 2
Zhou et al. Synergistic viral replication of Marek’s disease virus and avian leukosis virus subgroup J is responsible for the enhanced pathogenicity in the superinfection of chickens
Bertzbach et al. IFNα and IFNγ Impede Marek’s Disease Progression
Baj et al. Viral infections in burn patients: a state-of-the-art review
Michelitsch et al. In vivo characterization of tick-borne encephalitis virus in bank voles (Myodes glareolus)
Gao et al. The African swine fever virus with MGF360 and MGF505 deleted reduces the apoptosis of porcine alveolar macrophages by inhibiting the NF-κB signaling pathway and interleukin-1β
Canter et al. Serum neutralizing and enhancing effects on African swine fever virus infectivity in adherent pig PBMC
Franzoni et al. Analyses of the impact of immunosuppressive cytokines on porcine macrophage responses and susceptibility to infection to African swine fever viruses
Zhang et al. Vaccination with Omicron inactivated vaccine in pre-vaccinated mice protects against SARS-CoV-2 prototype and Omicron variants
Fan et al. Host responses to live-attenuated ASFV (HLJ/18–7GD)
Zhou et al. Isolation and characterization of two pseudorabies virus and evaluation of their effects on host natural immune responses and pathogenicity
Cano et al. Seroconversion and skin mucosal parameters during koi herpesvirus shedding in common carp, Cyprinus carpio
Anderson et al. Effect of viral strain and host age on clinical disease and viral replication in immunocompetent mouse models of Chikungunya Encephalomyelitis
Sato et al. Effect of insertion and deletion in the Meq Protein encoded by highly Oncogenic Marek’s disease virus on transactivation activity and virulence